AtriCureStock Price and Value Analysis

Should you buy AtriCure stock? (NasdaqGM:ATRC). Let's see how it does in our automated value investing analysis system.

AdvantagesDisadvantagesNeutral
  • This company is solid.
  • This company is not making money.
  • This stock looks overpriced.
  • This company has wild ups and downs.
  • This company pays no dividend.

Inside the ATRC Numbers

ATRC Price
(AtriCure stock price per share)
$17.96
[?] PE Ratio versus Sector 100% lower than other Healthcare stocks
[?] PE Ratio versus Industry 100% lower than other Medical Instruments & Supplies stocks
[?] Cash Yield -0.79%
[?] Free Cash Flow Jitter 69%

Is AtriCure Stock on Sale?

Based on our analysis, we believe that you should not buy AtriCure right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy ATRC Stock?

Does AtriCure have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.